WLKP Westlake Chemical Partners LP
Industrial Organic Chemicals · NYSE · SEC CIK 1604665 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.4%
TTM net income YoY20.4%
TTM EPS YoY—
Revenue 3-yr CAGR-0.5%
Net income 3-yr CAGR1.4%
Margins
Gross margin31.4%
Operating margin29.0%
Net margin4.8%
FCF margin35.8%
EBITDA margin38.0%
Returns
ROE—
ROA4.7%
ROIC (approx.)—
Asset turnover0.99x
Leverage & solvency
Liabilities / assets37.1%
Debt / equity—
Current ratio3.52x
Interest coverage17.25x
Cash quality & payout
Operating cash flow / net income8.16x
Accruals ratio-33.9%
Payout ratio—
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $314.46M | $297.10M | $305.68M | $323.05M | $308.90M | $297.12M | $237.63M | $290.06M |
| Cost of revenue | $210.56M | $202.29M | $211.92M | $226.24M | $209.47M | $199.59M | $183.55M | $191.48M |
| Gross profit | $103.90M | $94.81M | $93.76M | $96.81M | $99.42M | $97.53M | $54.08M | $98.58M |
| SG&A expense | $8.34M | $7.49M | $7.19M | $7.05M | $7.44M | $6.30M | $7.47M | $6.56M |
| Operating income | $95.56M | $87.31M | $86.57M | $89.76M | $91.98M | $91.23M | $46.61M | $92.03M |
| Interest expense | $5.11M | $5.12M | $5.08M | $5.51M | $5.95M | $5.91M | $5.54M | $5.77M |
| Pretax income | $91.02M | $82.54M | $81.83M | $84.45M | $86.26M | $86.00M | $42.42M | $87.59M |
| Income tax | $158,000 | $178,000 | $177,000 | $193,000 | $42,000 | $205,000 | $107,000 | $202,000 |
| Net income | $16.22M | $14.24M | $14.17M | $14.54M | $14.65M | $14.56M | $4.95M | $15.00M |
| EBITDA | $115.96M | $110.22M | $120.87M | $124.31M | $113.94M | $112.82M | $73.67M | $119.50M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $47.65M | $49.32M | $44.29M | $44.27M | $37.94M | $36.58M | $49.62M | $58.32M |
| Receivables | $22.94M | $21.60M | $19.78M | $9.11M | $16.14M | $12.82M | $13.01M | $11.58M |
| Inventory | $4.46M | $3.56M | $3.09M | $2.77M | $3.08M | $3.26M | $2.73M | $4.06M |
| Current assets | $184.47M | $157.54M | $148.90M | $143.51M | $130.86M | $156.52M | $225.15M | $240.93M |
| PP&E, net | $852.43M | $858.64M | $871.61M | $886.01M | $902.81M | $902.06M | $903.50M | $903.59M |
| Goodwill | $5.81M | $5.81M | $5.81M | $5.81M | $5.81M | $5.81M | $5.81M | $5.81M |
| Total assets | $1.23B | $1.22B | $1.24B | $1.26B | $1.27B | $1.31B | $1.37B | $1.29B |
| Current liabilities | $52.45M | $45.77M | $40.79M | $51.30M | $55.13M | $72.91M | $164.82M | $55.37M |
| Total liabilities | $454.92M | $447.94M | $443.31M | $454.18M | $458.30M | $476.02M | $568.25M | $458.64M |
| Shareholders' equity | — | — | — | — | — | — | — | — |
| Cash flow statement | ||||||||
| Operating cash flow | $122.16M | $129.85M | $110.20M | $120.38M | $105.24M | $9.07M | $45.78M | $132.47M |
| Capital expenditure | $11.69M | $12.48M | $5.56M | $8.83M | $29.65M | $24.38M | $15.96M | $13.47M |
| Free cash flow | $110.47M | $117.37M | $104.64M | $111.55M | $75.59M | -$15.31M | $29.82M | $119.00M |
| Investing cash flow | -$33.69M | -$19.48M | -$18.56M | -$18.83M | $348,000 | $35.62M | $14.04M | -$38.47M |
| Financing cash flow | -$90.14M | -$105.33M | -$91.62M | -$95.22M | -$104.23M | -$57.74M | -$68.52M | -$95.89M |
| Depreciation & amortization | $20.40M | $22.91M | $34.30M | $34.55M | $21.97M | $21.59M | $27.07M | $27.48M |
Free plan shows the latest 8 periods; Pro shows all 54 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.